{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T23:03:48Z","timestamp":1777158228546,"version":"3.51.4"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that is characterized by loss of motor neurons and atrophy of skeletal muscle. Current FDA-approved drugs to treat ALS are only modestly effective at slowing the progression of the disease. Rodents have been the standard preclinical animal model for testing candidate ALS drugs; however, alternative animal models, including zebrafish, are being studied to accelerate therapeutic discovery. Here, we sought to advance a model of ALS in zebrafish with associated tools to serve as biomarkers of neuromuscular deterioration. Thus, we applied noninvasive, surface electrical impedance myography (EIM) methodology to SOD1<jats:sup>G93A<\/jats:sup> zebrafish and control animals to evaluate its ability to serve as an electrophysiological biomarker of disease in ALS zebrafish. Measurements were acquired from the caudal musculature of animals at 2 time points by applying an alternating current at 41 frequencies (1\u00a0kHz\u20131\u00a0MHz) and measuring the resulting voltages. At the first time point, SOD1<jats:sup>G93A<\/jats:sup> animals still exhibited normal body morphometrics, spinal cord motor neuron numbers, and skeletal muscle mass, while at the second time point, these SOD1<jats:sup>G93A<\/jats:sup> animals exhibited reduced weight, loss of motor neurons, type 1 and 2 myofiber atrophy, and decreased capacity for endurance swimming. We found that non-invasive surface EIM detected the alterations observed in diseased ALS zebrafish at the second time point. Specifically, EIM measurements (phase angle, reactance, and resistance) at 2 and 50\u00a0kHz were robust metrics that distinguished between healthy and diseased zebrafish. To assess the reliability of our EIM technique in healthy and ALS zebrafish, we calculated the intraclass correlation coefficient and conducted Bland\u2013Altman analyses. The EIM methodology exhibited excellent reproducibility in both healthy and ALS zebrafish. In sum, these findings demonstrate that EIM is an effective tool to detect neuromuscular disease in symptomatic adult ALS zebrafish, and the approach described here offers a fast, noninvasive, and reliable platform that holds the potential to test candidate drug therapeutic efficacy.<\/jats:p>","DOI":"10.1038\/s41598-025-19830-w","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:45:42Z","timestamp":1760453142000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Surface electrical impedance myography detects disease in an adult-onset SOD1-G93A zebrafish model of amyotrophic lateral sclerosis"],"prefix":"10.1038","volume":"15","author":[{"given":"Seward B.","family":"Rutkove","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyansh","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Hevenor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhrumil","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyler","family":"Mourey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice A.","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjali K.","family":"Nath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"19830_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen, D. R. et al. Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59\u201362. https:\/\/doi.org\/10.1038\/362059a0 (1993).","journal-title":"Nature"},{"key":"19830_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/nn.3584","volume":"17","author":"AE Renton","year":"2014","unstructured":"Renton, A. E., Chio, A. & Traynor, B. J. State of play in amyotrophic lateral sclerosis genetics. Nat. Neurosci. 17, 17\u201323. https:\/\/doi.org\/10.1038\/nn.3584 (2014).","journal-title":"Nat. Neurosci."},{"key":"19830_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown, R. H. & Al-Chalabi, A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 377, 162\u2013172. https:\/\/doi.org\/10.1056\/NEJMra1603471 (2017).","journal-title":"N. Engl. J. Med."},{"key":"19830_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.105156","volume":"147","author":"A Shatunov","year":"2021","unstructured":"Shatunov, A. & Al-Chalabi, A. The genetic architecture of ALS. Neurobiol. Dis. 147, 105156. https:\/\/doi.org\/10.1016\/j.nbd.2020.105156 (2021).","journal-title":"Neurobiol. Dis."},{"key":"19830_CR5","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/jnnp-2016-315018","volume":"88","author":"ZY Zou","year":"2017","unstructured":"Zou, Z. Y. et al. Genetic epidemiology of amyotrophic lateral sclerosis: A systematic review and meta-analysis. J. Neurol. Neurosurg. Psychiatry 88, 540\u2013549. https:\/\/doi.org\/10.1136\/jnnp-2016-315018 (2017).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"19830_CR6","doi-asserted-by":"publisher","unstructured":"Sagiraju, H. K. R. et al. Amyotrophic lateral sclerosis among veterans deployed in support of post-9\/11 U.S. conflicts. Mil. Med. 185, e501-e509 (2020). https:\/\/doi.org\/10.1093\/milmed\/usz350 (2020).","DOI":"10.1093\/milmed\/usz350"},{"key":"19830_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000453359","volume":"17","author":"AS Andrew","year":"2017","unstructured":"Andrew, A. S. et al. Environmental and occupational exposures and amyotrophic lateral sclerosis in New England. Neurodegener. Dis. 17, 110\u2013116. https:\/\/doi.org\/10.1159\/000453359 (2017).","journal-title":"Neurodegener. Dis."},{"key":"19830_CR8","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00415-021-10928-5","volume":"269","author":"DB Re","year":"2022","unstructured":"Re, D. B. et al. A perspective on persistent toxicants in veterans and amyotrophic lateral sclerosis: Identifying exposures determining higher ALS risk. J. Neurol. 269, 2359\u20132377. https:\/\/doi.org\/10.1007\/s00415-021-10928-5 (2022).","journal-title":"J. Neurol."},{"key":"19830_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000315405","volume":"8","author":"B Callaghan","year":"2011","unstructured":"Callaghan, B., Feldman, D., Gruis, K. & Feldman, E. The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications. Neurodegener. Dis. 8, 1\u20138. https:\/\/doi.org\/10.1159\/000315405 (2011).","journal-title":"Neurodegener. Dis."},{"key":"19830_CR10","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1001\/jamaneurol.2016.0594","volume":"73","author":"FC Su","year":"2016","unstructured":"Su, F. C. et al. Association of environmental toxins with amyotrophic lateral sclerosis. JAMA Neurol. 73, 803\u2013811. https:\/\/doi.org\/10.1001\/jamaneurol.2016.0594 (2016).","journal-title":"JAMA Neurol."},{"key":"19830_CR11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/jnnp-2011-300188","volume":"83","author":"J Phukan","year":"2012","unstructured":"Phukan, J. et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: A population-based study. J. Neurol. Neurosurg. Psychiatry 83, 102\u2013108. https:\/\/doi.org\/10.1136\/jnnp-2011-300188 (2012).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"19830_CR12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnins.2020.00042","volume":"14","author":"YA Abramzon","year":"2020","unstructured":"Abramzon, Y. A., Fratta, P., Traynor, B. J. & Chia, R. The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Front. Neurosci. 14, 42. https:\/\/doi.org\/10.3389\/fnins.2020.00042 (2020).","journal-title":"Front. Neurosci."},{"key":"19830_CR13","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1073\/pnas.93.7.3155","volume":"93","author":"PH Tu","year":"1996","unstructured":"Tu, P. H. et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. USA 93, 3155\u20133160. https:\/\/doi.org\/10.1073\/pnas.93.7.3155 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"19830_CR14","doi-asserted-by":"publisher","unstructured":"Philips, T. & Rothstein, J. D. Rodent models of amyotrophic lateral sclerosis. Curr. Protoc. Pharmacol. 69, 61\u201365 (2015). https:\/\/doi.org\/10.1002\/0471141755.ph0567s69","DOI":"10.1002\/0471141755.ph0567s69"},{"key":"19830_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/507423a","volume":"507","author":"S Perrin","year":"2014","unstructured":"Perrin, S. Preclinical research: Make mouse studies work. Nature 507, 423\u2013425. https:\/\/doi.org\/10.1038\/507423a (2014).","journal-title":"Nature"},{"key":"19830_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2006.12.015","volume":"26","author":"M Benatar","year":"2007","unstructured":"Benatar, M. Lost in translation: Treatment trials in the SOD1 mouse and in human ALS. Neurobiol. Dis. 26, 1\u201313. https:\/\/doi.org\/10.1016\/j.nbd.2006.12.015 (2007).","journal-title":"Neurobiol. Dis."},{"key":"19830_CR17","doi-asserted-by":"publisher","unstructured":"Wong, C. et al. Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective. Brain Commun. 3, fcab242 (2021). https:\/\/doi.org\/10.1093\/braincomms\/fcab242","DOI":"10.1093\/braincomms\/fcab242"},{"key":"19830_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fnmol.2017.00405","volume":"10","author":"AP Tosolini","year":"2017","unstructured":"Tosolini, A. P. & Sleigh, J. N. Motor neuron gene therapy: Lessons from spinal muscular atrophy for amyotrophic lateral sclerosis. Front. Mol. Neurosci. 10, 405. https:\/\/doi.org\/10.3389\/fnmol.2017.00405 (2017).","journal-title":"Front. Mol. Neurosci."},{"key":"19830_CR19","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1080\/17460441.2024.2387791","volume":"19","author":"L Lescouzeres","year":"2024","unstructured":"Lescouzeres, L. & Patten, S. A. Promising animal models for amyotrophic lateral sclerosis drug discovery: A comprehensive update. Expert Opin. Drug Discov. 19, 1213\u20131233. https:\/\/doi.org\/10.1080\/17460441.2024.2387791 (2024).","journal-title":"Expert Opin. Drug Discov."},{"key":"19830_CR20","doi-asserted-by":"publisher","unstructured":"Bonifacino, T. et al. Nearly 30 years of animal models to study amyotrophic lateral sclerosis: A historical overview and future perspectives. Int. J. Mol. Sci. 22 (2021). https:\/\/doi.org\/10.3390\/ijms222212236","DOI":"10.3390\/ijms222212236"},{"key":"19830_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105138","volume":"148","author":"NAS Oliveira","year":"2023","unstructured":"Oliveira, N. A. S., Pinho, B. R. & Oliveira, J. M. A. Swimming against ALS: How to model disease in zebrafish for pathophysiological and behavioral studies. Neurosci. Biobehav. Rev. 148, 105138. https:\/\/doi.org\/10.1016\/j.neubiorev.2023.105138 (2023).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"19830_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.gep.2018.08.003","volume":"30","author":"LA Laboissonniere","year":"2018","unstructured":"Laboissonniere, L. A. et al. ALS-associated genes display CNS expression in the developing zebrafish. Gene Expr. Patterns 30, 14\u201331. https:\/\/doi.org\/10.1016\/j.gep.2018.08.003 (2018).","journal-title":"Gene Expr. Patterns"},{"key":"19830_CR23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1242\/dmm.029058","volume":"10","author":"P Van Damme","year":"2017","unstructured":"Van Damme, P., Robberecht, W. & Van Den Bosch, L. Modelling amyotrophic lateral sclerosis: Progress and possibilities. Dis. Model. Mech. 10, 537\u2013549. https:\/\/doi.org\/10.1242\/dmm.029058 (2017).","journal-title":"Dis. Model. Mech."},{"key":"19830_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2021.136041","volume":"759","author":"E Braems","year":"2021","unstructured":"Braems, E., Tziortzouda, P. & Van Den Bosch, L. Exploring the alternative: Fish, flies and worms as preclinical models for ALS. Neurosci. Lett. 759, 136041. https:\/\/doi.org\/10.1016\/j.neulet.2021.136041 (2021).","journal-title":"Neurosci. Lett."},{"key":"19830_CR25","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1242\/dmm.015719","volume":"7","author":"SA Patten","year":"2014","unstructured":"Patten, S. A. et al. Fishing for causes and cures of motor neuron disorders. Dis. Model. Mech. 7, 799\u2013809. https:\/\/doi.org\/10.1242\/dmm.015719 (2014).","journal-title":"Dis. Model. Mech."},{"key":"19830_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.940484","volume":"15","author":"K Chia","year":"2022","unstructured":"Chia, K., Klingseisen, A., Sieger, D. & Priller, J. Zebrafish as a model organism for neurodegenerative disease. Front. Mol. Neurosci. 15, 940484. https:\/\/doi.org\/10.3389\/fnmol.2022.940484 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"19830_CR27","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/nature12111","volume":"496","author":"K Howe","year":"2013","unstructured":"Howe, K. et al. The zebrafish reference genome sequence and its relationship to the human genome. Nature 496, 498\u2013503. https:\/\/doi.org\/10.1038\/nature12111 (2013).","journal-title":"Nature"},{"key":"19830_CR28","doi-asserted-by":"publisher","unstructured":"Kalueff, A. V. et al. Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish 10, 70\u201386 (2013). https:\/\/doi.org\/10.1089\/zeb.2012.0861","DOI":"10.1089\/zeb.2012.0861"},{"key":"19830_CR29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3389\/fneur.2018.00347","volume":"9","author":"RL Vaz","year":"2018","unstructured":"Vaz, R. L., Outeiro, T. F. & Ferreira, J. J. Zebrafish as an animal model for drug discovery in Parkinson\u2019s disease and other movement disorders: A systematic review. Front. Neurol. 9, 347. https:\/\/doi.org\/10.3389\/fneur.2018.00347 (2018).","journal-title":"Front. Neurol."},{"key":"19830_CR30","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/nmeth.3581","volume":"12","author":"O Randlett","year":"2015","unstructured":"Randlett, O. et al. Whole-brain activity mapping onto a zebrafish brain atlas. Nat. Methods 12, 1039\u20131046. https:\/\/doi.org\/10.1038\/nmeth.3581 (2015).","journal-title":"Nat. Methods"},{"key":"19830_CR31","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/ana.23780","volume":"73","author":"A McGown","year":"2013","unstructured":"McGown, A. et al. Early interneuron dysfunction in ALS: Insights from a mutant sod1 zebrafish model. Ann. Neurol. 73, 246\u2013258. https:\/\/doi.org\/10.1002\/ana.23780 (2013).","journal-title":"Ann. Neurol."},{"key":"19830_CR32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1089\/zeb.2018.1588","volume":"16","author":"KJ Robinson","year":"2019","unstructured":"Robinson, K. J. et al. Motor neuron abnormalities correlate with impaired movement in zebrafish that express mutant superoxide dismutase 1. Zebrafish 16, 8\u201314. https:\/\/doi.org\/10.1089\/zeb.2018.1588 (2019).","journal-title":"Zebrafish"},{"key":"19830_CR33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.expneurol.2018.03.002","volume":"304","author":"TH Yeh","year":"2018","unstructured":"Yeh, T. H. et al. C9orf72 is essential for neurodevelopment and motility mediated by Cyclin G1. Exp. Neurol. 304, 114\u2013124. https:\/\/doi.org\/10.1016\/j.expneurol.2018.03.002 (2018).","journal-title":"Exp. Neurol."},{"key":"19830_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104935","volume":"142","author":"AR Bourefis","year":"2020","unstructured":"Bourefis, A. R., Campanari, M. L., Buee-Scherrer, V. & Kabashi, E. Functional characterization of a FUS mutant zebrafish line as a novel genetic model for ALS. Neurobiol. Dis. 142, 104935. https:\/\/doi.org\/10.1016\/j.nbd.2020.104935 (2020).","journal-title":"Neurobiol. Dis."},{"key":"19830_CR35","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1093\/hmg\/ddt082","volume":"22","author":"CA Hewamadduma","year":"2013","unstructured":"Hewamadduma, C. A. et al. Tardbpl splicing rescues motor neuron and axonal development in a mutant tardbp zebrafish. Hum. Mol. Genet. 22, 2376\u20132386. https:\/\/doi.org\/10.1093\/hmg\/ddt082 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"19830_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1750-1326-7-44","volume":"7","author":"SA Sakowski","year":"2012","unstructured":"Sakowski, S. A. et al. Neuromuscular effects of G93A-SOD1 expression in zebrafish. Mol. Neurodegener. 7, 44. https:\/\/doi.org\/10.1186\/1750-1326-7-44 (2012).","journal-title":"Mol. Neurodegener."},{"key":"19830_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1242\/dmm.012013","volume":"7","author":"MM Da Costa","year":"2014","unstructured":"Da Costa, M. M. et al. A new zebrafish model produced by TILLING of SOD1-related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for in vivo therapeutic screening. Dis. Model Mech. 7, 73\u201381. https:\/\/doi.org\/10.1242\/dmm.012013 (2014).","journal-title":"Dis. Model Mech."},{"key":"19830_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s40478-018-0629-7","volume":"6","author":"MP Shaw","year":"2018","unstructured":"Shaw, M. P. et al. Stable transgenic C9orf72 zebrafish model key aspects of the ALS\/FTD phenotype and reveal novel pathological features. Acta Neuropathol. Commun. 6, 125. https:\/\/doi.org\/10.1186\/s40478-018-0629-7 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"19830_CR39","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1242\/dmm.005538","volume":"3","author":"T Ramesh","year":"2010","unstructured":"Ramesh, T. et al. A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Dis. Model Mech. 3, 652\u2013662. https:\/\/doi.org\/10.1242\/dmm.005538 (2010).","journal-title":"Dis. Model Mech."},{"key":"19830_CR40","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1038\/s44318-024-00136-y","volume":"43","author":"U Kumar","year":"2024","unstructured":"Kumar, U. et al. Whole-body replacement of larval myofibers generates permanent adult myofibers in zebrafish. EMBO J. 43, 3090\u20133115. https:\/\/doi.org\/10.1038\/s44318-024-00136-y (2024).","journal-title":"EMBO J."},{"key":"19830_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-385940-2.00001-2","volume":"96","author":"M Murphy","year":"2011","unstructured":"Murphy, M. & Kardon, G. Origin of vertebrate limb muscle: The role of progenitor and myoblast populations. Curr. Top. Dev. Biol. 96, 1\u201332. https:\/\/doi.org\/10.1016\/B978-0-12-385940-2.00001-2 (2011).","journal-title":"Curr. Top. Dev. Biol."},{"key":"19830_CR42","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1093\/brain\/awad202","volume":"146","author":"JM Shefner","year":"2023","unstructured":"Shefner, J. M. et al. Skeletal muscle in amyotrophic lateral sclerosis. Brain 146, 4425\u20134436. https:\/\/doi.org\/10.1093\/brain\/awad202 (2023).","journal-title":"Brain"},{"key":"19830_CR43","doi-asserted-by":"publisher","unstructured":"Quessada, C. et al. Skeletal muscle metabolism: Origin or prognostic factor for amyotrophic lateral sclerosis (ALS) development? Cells (2021). https:\/\/doi.org\/10.3390\/cells10061449","DOI":"10.3390\/cells10061449"},{"key":"19830_CR44","doi-asserted-by":"publisher","unstructured":"Dupuis, L., Oudart, H., Rene, F., Gonzalez de Aguilar, J. L. & Loeffler, J. P. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: Benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. USA 101, 11159\u201311164 (2004). https:\/\/doi.org\/10.1073\/pnas.0402026101","DOI":"10.1073\/pnas.0402026101"},{"key":"19830_CR45","doi-asserted-by":"publisher","first-page":"526","DOI":"10.15252\/emmm.201404433","volume":"7","author":"L Palamiuc","year":"2015","unstructured":"Palamiuc, L. et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med. 7, 526\u2013546. https:\/\/doi.org\/10.15252\/emmm.201404433 (2015).","journal-title":"EMBO Mol. Med."},{"key":"19830_CR46","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/201696","volume":"2011","author":"K Sakuma","year":"2011","unstructured":"Sakuma, K. & Yamaguchi, A. The recent understanding of the neurotrophin\u2019s role in skeletal muscle adaptation. J. Biomed. Biotechnol. 2011, 201696. https:\/\/doi.org\/10.1155\/2011\/201696 (2011).","journal-title":"J. Biomed. Biotechnol."},{"key":"19830_CR47","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1093\/hmg\/ddq106","volume":"19","author":"M Wong","year":"2010","unstructured":"Wong, M. & Martin, L. J. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 19, 2284\u20132302. https:\/\/doi.org\/10.1093\/hmg\/ddq106 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"19830_CR48","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/mus.26187","volume":"58","author":"K Kapur","year":"2018","unstructured":"Kapur, K., Nagy, J. A., Taylor, R. S., Sanchez, B. & Rutkove, S. B. Estimating myofiber size with electrical impedance myography: A study in amyotrophic lateral sclerosis MICE. Muscle Nerve 58, 713\u2013717. https:\/\/doi.org\/10.1002\/mus.26187 (2018).","journal-title":"Muscle Nerve"},{"key":"19830_CR49","doi-asserted-by":"publisher","first-page":"1059743","DOI":"10.3389\/fneur.2022.1059743","volume":"13","author":"JA Nagy","year":"2022","unstructured":"Nagy, J. A., Semple, C., Lo, P. & Rutkove, S. B. Assessing the therapeutic impact of resveratrol in ALS SOD1-G93A mice with electrical impedance myography. Front. Neurol. 13, 1059743. https:\/\/doi.org\/10.3389\/fneur.2022.1059743 (2022).","journal-title":"Front. Neurol."},{"key":"19830_CR50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s13311-016-0491-x","volume":"14","author":"B Sanchez","year":"2017","unstructured":"Sanchez, B. & Rutkove, S. B. Electrical impedance myography and its applications in neuromuscular disorders. Neurotherapeutics 14, 107\u2013118. https:\/\/doi.org\/10.1007\/s13311-016-0491-x (2017).","journal-title":"Neurotherapeutics"},{"key":"19830_CR51","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/mus.27664","volume":"66","author":"SR Pandeya","year":"2022","unstructured":"Pandeya, S. R. et al. Using machine learning algorithms to enhance the diagnostic performance of electrical impedance myography. Muscle Nerve 66, 354\u2013361. https:\/\/doi.org\/10.1002\/mus.27664 (2022).","journal-title":"Muscle Nerve"},{"key":"19830_CR52","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/acn3.51096","volume":"7","author":"SB Rutkove","year":"2020","unstructured":"Rutkove, S. B. et al. Improved ALS clinical trials through frequent at-home self-assessment: A proof of concept study. Ann. Clin. Transl. Neurol. 7, 1148\u20131157. https:\/\/doi.org\/10.1002\/acn3.51096 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"19830_CR53","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/21678421.2018.1510008","volume":"19","author":"JM Shefner","year":"2018","unstructured":"Shefner, J. M. et al. Reducing sample size requirements for future ALS clinical trials with a dedicated electrical impedance myography system. Amyotroph. Lateral Scler. Frontotemporal Degener. 19, 555\u2013561. https:\/\/doi.org\/10.1080\/21678421.2018.1510008 (2018).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"19830_CR54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/acn3.50958","volume":"7","author":"ML Leitner","year":"2020","unstructured":"Leitner, M. L. et al. Electrical impedance myography for reducing sample size in Duchenne muscular dystrophy trials. Ann. Clin. Transl. Neurol. 7, 4\u201314. https:\/\/doi.org\/10.1002\/acn3.50958 (2020).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"19830_CR55","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ana.24874","volume":"81","author":"SB Rutkove","year":"2017","unstructured":"Rutkove, S. B. et al. Electrical impedance myography for assessment of Duchenne muscular dystrophy. Ann. Neurol. 81, 622\u2013632. https:\/\/doi.org\/10.1002\/ana.24874 (2017).","journal-title":"Ann. Neurol."},{"key":"19830_CR56","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034405","author":"SB Rutkove","year":"2019","unstructured":"Rutkove, S. B. & Sanchez, B. Electrical Impedance Methods in Neuromuscular Assessment: An Overview. Cold Spring Harb. Perspect. Med. https:\/\/doi.org\/10.1101\/cshperspect.a034405 (2019).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"19830_CR57","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1002\/mus.24086","volume":"49","author":"J Li","year":"2014","unstructured":"Li, J. et al. Electrical impedance myography for the in vivo and ex vivo assessment of muscular dystrophy (mdx) mouse muscle. Muscle Nerve 49, 829\u2013835. https:\/\/doi.org\/10.1002\/mus.24086 (2014).","journal-title":"Muscle Nerve"},{"key":"19830_CR58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185614","volume":"12","author":"WD Arnold","year":"2017","unstructured":"Arnold, W. D. et al. Electrical impedance myography detects age-related muscle change in mice. PLoS ONE 12, e0185614. https:\/\/doi.org\/10.1371\/journal.pone.0185614 (2017).","journal-title":"PLoS ONE"},{"key":"19830_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26111","author":"K Kapur","year":"2018","unstructured":"Kapur, K. et al. Predicting myofiber size with electrical impedance myography: A study in immature mice. Muscle Nerve https:\/\/doi.org\/10.1002\/mus.26111 (2018).","journal-title":"Muscle Nerve"},{"key":"19830_CR60","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1002\/mus.27240","volume":"63","author":"SR Pandeya","year":"2021","unstructured":"Pandeya, S. R. et al. Estimating myofiber cross-sectional area and connective tissue deposition with electrical impedance myography: A study in D2-mdx mice. Muscle Nerve 63, 941\u2013950. https:\/\/doi.org\/10.1002\/mus.27240 (2021).","journal-title":"Muscle Nerve"},{"key":"19830_CR61","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3109\/21678421.2016.1165258","volume":"17","author":"J Li","year":"2016","unstructured":"Li, J., Pacheck, A., Sanchez, B. & Rutkove, S. B. Single and modeled multifrequency electrical impedance myography parameters and their relationship to force production in the ALS SOD1G93A mouse. Amyotroph. Lateral Scler. Frontotemporal Degener. 17, 397\u2013403. https:\/\/doi.org\/10.3109\/21678421.2016.1165258 (2016).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"19830_CR62","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0259071","volume":"16","author":"SR Pandeya","year":"2021","unstructured":"Pandeya, S. R. et al. Relationships between in vivo surface and ex vivo electrical impedance myography measurements in three different neuromuscular disorder mouse models. PLoS ONE 16, e0259071. https:\/\/doi.org\/10.1371\/journal.pone.0259071 (2021).","journal-title":"PLoS ONE"},{"key":"19830_CR63","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/j.clinph.2011.04.021","volume":"122","author":"LL Wang","year":"2011","unstructured":"Wang, L. L., Spieker, A. J., Li, J. & Rutkove, S. B. Electrical impedance myography for monitoring motor neuron loss in the SOD1 G93A amyotrophic lateral sclerosis rat. Clin. Neurophysiol. 122, 2505\u20132511. https:\/\/doi.org\/10.1016\/j.clinph.2011.04.021 (2011).","journal-title":"Clin. Neurophysiol."},{"key":"19830_CR64","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.clinph.2007.08.004","volume":"118","author":"SB Rutkove","year":"2007","unstructured":"Rutkove, S. B. et al. Electrical impedance myography to assess outcome in amyotrophic lateral sclerosis clinical trials. Clin. Neurophysiol. 118, 2413\u20132418. https:\/\/doi.org\/10.1016\/j.clinph.2007.08.004 (2007).","journal-title":"Clin. Neurophysiol."},{"key":"19830_CR65","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/17482968.2012.688837","volume":"13","author":"SB Rutkove","year":"2012","unstructured":"Rutkove, S. B. et al. Electrical impedance myography as a biomarker to assess ALS progression. Amyotroph. Lateral Scler. 13, 439\u2013445. https:\/\/doi.org\/10.3109\/17482968.2012.688837 (2012).","journal-title":"Amyotroph. Lateral Scler."},{"key":"19830_CR66","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/mus.24128","volume":"49","author":"SB Rutkove","year":"2014","unstructured":"Rutkove, S. B. et al. Electrical impedance myography correlates with standard measures of ALS severity. Muscle Nerve 49, 441\u2013443. https:\/\/doi.org\/10.1002\/mus.24128 (2014).","journal-title":"Muscle Nerve"},{"key":"19830_CR67","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.clinph.2015.06.021","volume":"127","author":"C McIlduff","year":"2016","unstructured":"McIlduff, C. et al. An improved electrical impedance myography (EIM) tongue array for use in clinical trials. Clin. Neurophysiol. 127, 932\u2013935. https:\/\/doi.org\/10.1016\/j.clinph.2015.06.021 (2016).","journal-title":"Clin. Neurophysiol."},{"key":"19830_CR68","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/21678421.2020.1752247","volume":"21","author":"MB Offit","year":"2020","unstructured":"Offit, M. B., Wu, T., Floeter, M. K. & Lehky, T. J. Electrical impedance myography (EIM) in a natural history study of C9ORF72 mutation carriers. Amyotroph. Lateral Scler. Frontotemporal Degener. 21, 445\u2013451. https:\/\/doi.org\/10.1080\/21678421.2020.1752247 (2020).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"19830_CR69","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.clinph.2022.04.015","volume":"139","author":"CN Schooling","year":"2022","unstructured":"Schooling, C. N. et al. Tensor electrical impedance myography identifies bulbar disease progression in amyotrophic lateral sclerosis. Clin. Neurophysiol. 139, 69\u201375. https:\/\/doi.org\/10.1016\/j.clinph.2022.04.015 (2022).","journal-title":"Clin. Neurophysiol."},{"key":"19830_CR70","doi-asserted-by":"publisher","first-page":"7191","DOI":"10.1038\/s41598-023-34119-6","volume":"13","author":"SB Rutkove","year":"2023","unstructured":"Rutkove, S. B. et al. Electrical impedance myography detects age-related skeletal muscle atrophy in adult zebrafish. Sci. Rep. 13, 7191. https:\/\/doi.org\/10.1038\/s41598-023-34119-6 (2023).","journal-title":"Sci. Rep."},{"key":"19830_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11071938","author":"SB Rutkove","year":"2023","unstructured":"Rutkove, S. B. et al. Surface electrical impedance myography detects skeletal muscle atrophy in aged wildtype zebrafish and aged gpr27 knockout zebrafish. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines11071938 (2023).","journal-title":"Biomedicines."},{"key":"19830_CR72","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/nar\/29.1.87","volume":"29","author":"J Sprague","year":"2001","unstructured":"Sprague, J., Doerry, E., Douglas, S. & Westerfield, M. The Zebrafish Information Network (ZFIN): A resource for genetic, genomic and developmental research. Nucleic Acids Res. 29, 87\u201390. https:\/\/doi.org\/10.1093\/nar\/29.1.87 (2001).","journal-title":"Nucleic Acids Res."},{"key":"19830_CR73","doi-asserted-by":"publisher","first-page":"24515","DOI":"10.1038\/srep24515","volume":"6","author":"L Benedetti","year":"2016","unstructured":"Benedetti, L. et al. INaP selective inhibition reverts precocious inter- and motorneurons hyperexcitability in the Sod1-G93R zebrafish ALS model. Sci. Rep. 6, 24515. https:\/\/doi.org\/10.1038\/srep24515 (2016).","journal-title":"Sci. Rep."},{"key":"19830_CR74","unstructured":"Highley, J. R. & Sullivan, N. in Bancroft\u2019s Theory and Practice of Histological Techniques (Eighth Edition) (eds S. Kim Suvarna, Christopher Layton, & John D. Bancroft) 306\u2013336 (Elsevier, 2019)."},{"key":"19830_CR75","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo, T. K. & Li, M. Y. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15, 155\u2013163. https:\/\/doi.org\/10.1016\/j.jcm.2016.02.012 (2016).","journal-title":"J Chiropr Med"},{"key":"19830_CR76","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.41973","author":"E Martineau","year":"2018","unstructured":"Martineau, E., Di Polo, A., Vande Velde, C. & Robitaille, R. Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS. Elife https:\/\/doi.org\/10.7554\/eLife.41973 (2018).","journal-title":"Elife"},{"key":"19830_CR77","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/j.neuron.2021.12.019","volume":"110","author":"S Zhang","year":"2022","unstructured":"Zhang, S. et al. Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis. Neuron 110, 992\u20131008. https:\/\/doi.org\/10.1016\/j.neuron.2021.12.019 (2022).","journal-title":"Neuron"},{"key":"19830_CR78","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/s41573-021-00210-8","volume":"20","author":"EE Patton","year":"2021","unstructured":"Patton, E. E., Zon, L. I. & Langenau, D. M. Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials. Nat. Rev. Drug Discov. 20, 611\u2013628. https:\/\/doi.org\/10.1038\/s41573-021-00210-8 (2021).","journal-title":"Nat. Rev. Drug Discov."},{"key":"19830_CR79","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1021\/acschemneuro.2c00583","volume":"13","author":"P Bhattarai","year":"2022","unstructured":"Bhattarai, P., Turgutalp, B. & Kizil, C. Zebrafish as an experimental and preclinical model for Alzheimer\u2019s disease. ACS Chem. Neurosci. 13, 2939\u20132941. https:\/\/doi.org\/10.1021\/acschemneuro.2c00583 (2022).","journal-title":"ACS Chem. Neurosci."},{"key":"19830_CR80","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/138920009787522197","volume":"10","author":"C Chakraborty","year":"2009","unstructured":"Chakraborty, C., Hsu, C. H., Wen, Z. H., Lin, C. S. & Agoramoorthy, G. Zebrafish: A complete animal model for in vivo drug discovery and development. Curr. Drug Metab. 10, 116\u2013124. https:\/\/doi.org\/10.2174\/138920009787522197 (2009).","journal-title":"Curr. Drug Metab."},{"key":"19830_CR81","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/nrd1606","volume":"4","author":"LI Zon","year":"2005","unstructured":"Zon, L. I. & Peterson, R. T. In vivo drug discovery in the zebrafish. Nat. Rev. Drug Discov. 4, 35\u201344. https:\/\/doi.org\/10.1038\/nrd1606 (2005).","journal-title":"Nat. Rev. Drug Discov."},{"key":"19830_CR82","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.944693","volume":"15","author":"K Ochenkowska","year":"2022","unstructured":"Ochenkowska, K., Herold, A. & Samarut, E. Zebrafish is a powerful tool for precision medicine approaches to neurological disorders. Front. Mol. Neurosci. 15, 944693. https:\/\/doi.org\/10.3389\/fnmol.2022.944693 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"19830_CR83","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10522-015-9631-7","volume":"17","author":"M McLeod","year":"2016","unstructured":"McLeod, M., Breen, L., Hamilton, D. L. & Philp, A. Live strong and prosper: The importance of skeletal muscle strength for healthy ageing. Biogerontology 17, 497\u2013510. https:\/\/doi.org\/10.1007\/s10522-015-9631-7 (2016).","journal-title":"Biogerontology"},{"key":"19830_CR84","doi-asserted-by":"publisher","DOI":"10.3390\/biom13050863","author":"K Maksimovic","year":"2023","unstructured":"Maksimovic, K., Youssef, M., You, J., Sung, H. K. & Park, J. Evidence of metabolic dysfunction in amyotrophic lateral sclerosis (ALS) patients and animal models. Biomolecules https:\/\/doi.org\/10.3390\/biom13050863 (2023).","journal-title":"Biomolecules"},{"key":"19830_CR85","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1007\/s00415-009-5100-z","volume":"256","author":"C Bouteloup","year":"2009","unstructured":"Bouteloup, C. et al. Hypermetabolism in ALS patients: An early and persistent phenomenon. J. Neurol. 256, 1236\u20131242. https:\/\/doi.org\/10.1007\/s00415-009-5100-z (2009).","journal-title":"J. Neurol."},{"key":"19830_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071793","volume":"8","author":"NR Stallings","year":"2013","unstructured":"Stallings, N. R. et al. TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasis. PLoS ONE 8, e71793. https:\/\/doi.org\/10.1371\/journal.pone.0071793 (2013).","journal-title":"PLoS ONE"},{"key":"19830_CR87","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40478-019-0824-1","volume":"7","author":"F Mori","year":"2019","unstructured":"Mori, F. et al. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta Neuropathol. Commun. 7, 165. https:\/\/doi.org\/10.1186\/s40478-019-0824-1 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"19830_CR88","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00401-024-02794-y","volume":"148","author":"M Zufiria","year":"2024","unstructured":"Zufiria, M. et al. Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis. Acta Neuropathol. 148, 43. https:\/\/doi.org\/10.1007\/s00401-024-02794-y (2024).","journal-title":"Acta Neuropathol."},{"key":"19830_CR89","doi-asserted-by":"publisher","unstructured":"Loeffler, J. P., Picchiarelli, G., Dupuis, L. & Gonzalez De Aguilar, J. L. The role of skeletal muscle in amyotrophic lateral sclerosis. Brain Pathol. 26, 227\u2013236 (2016). https:\/\/doi.org\/10.1111\/bpa.12350","DOI":"10.1111\/bpa.12350"},{"key":"19830_CR90","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.1523\/JNEUROSCI.21-10-03369.2001","volume":"21","author":"A Pramatarova","year":"2001","unstructured":"Pramatarova, A., Laganiere, J., Roussel, J., Brisebois, K. & Rouleau, G. A. Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J. Neurosci. 21, 3369\u20133374. https:\/\/doi.org\/10.1523\/JNEUROSCI.21-10-03369.2001 (2001).","journal-title":"J. Neurosci."},{"key":"19830_CR91","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1073\/pnas.0802556105","volume":"105","author":"K Yamanaka","year":"2008","unstructured":"Yamanaka, K. et al. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc. Natl. Acad. Sci. USA 105, 7594\u20137599. https:\/\/doi.org\/10.1073\/pnas.0802556105 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"19830_CR92","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.592851","volume":"11","author":"LJ Martin","year":"2020","unstructured":"Martin, L. J. & Wong, M. Skeletal muscle-restricted expression of human SOD1 in transgenic mice causes a fatal ALS-like syndrome. Front. Neurol. 11, 592851. https:\/\/doi.org\/10.3389\/fneur.2020.592851 (2020).","journal-title":"Front. Neurol."},{"key":"19830_CR93","doi-asserted-by":"publisher","first-page":"4825","DOI":"10.1523\/JNEUROSCI.22-12-04825.2002","volume":"22","author":"MM Lino","year":"2002","unstructured":"Lino, M. M., Schneider, C. & Caroni, P. Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J. Neurosci. 22, 4825\u20134832. https:\/\/doi.org\/10.1523\/JNEUROSCI.22-12-04825.2002 (2002).","journal-title":"J. Neurosci."},{"key":"19830_CR94","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1083\/jcb.200407021","volume":"168","author":"G Dobrowolny","year":"2005","unstructured":"Dobrowolny, G. et al. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J. Cell. Biol. 168, 193\u2013199. https:\/\/doi.org\/10.1083\/jcb.200407021 (2005).","journal-title":"J. Cell. Biol."},{"key":"19830_CR95","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/bpa.12774","volume":"30","author":"P Fabbrizio","year":"2020","unstructured":"Fabbrizio, P. et al. P2X7 activation enhances skeletal muscle metabolism and regeneration in SOD1G93A mouse model of amyotrophic lateral sclerosis. Brain Pathol. 30, 272\u2013282. https:\/\/doi.org\/10.1111\/bpa.12774 (2020).","journal-title":"Brain Pathol."},{"key":"19830_CR96","doi-asserted-by":"publisher","DOI":"10.3390\/cells10030525","author":"S Scaricamazza","year":"2021","unstructured":"Scaricamazza, S., Salvatori, I., Ferri, A. & Valle, C. Skeletal muscle in ALS: An unappreciated therapeutic opportunity?. Cells https:\/\/doi.org\/10.3390\/cells10030525 (2021).","journal-title":"Cells"},{"key":"19830_CR97","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.clinph.2020.11.014","volume":"132","author":"B Sanchez","year":"2021","unstructured":"Sanchez, B., Martinsen, O. G., Freeborn, T. J. & Furse, C. M. Electrical impedance myography: A critical review and outlook. Clin. Neurophysiol. 132, 338\u2013344. https:\/\/doi.org\/10.1016\/j.clinph.2020.11.014 (2021).","journal-title":"Clin. Neurophysiol."},{"key":"19830_CR98","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/mus.25561","volume":"56","author":"SB Rutkove","year":"2017","unstructured":"Rutkove, S. B., Pacheck, A. & Sanchez, B. Sensitivity distribution simulations of surface electrode configurations for electrical impedance myography. Muscle Nerve 56, 887\u2013895. https:\/\/doi.org\/10.1002\/mus.25561 (2017).","journal-title":"Muscle Nerve"},{"key":"19830_CR99","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0065976","volume":"8","author":"J Li","year":"2013","unstructured":"Li, J., Sung, M. & Rutkove, S. B. Electrophysiologic biomarkers for assessing disease progression and the effect of riluzole in SOD1 G93A ALS mice. PLoS ONE 8, e65976. https:\/\/doi.org\/10.1371\/journal.pone.0065976 (2013).","journal-title":"PLoS ONE"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19830-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19830-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19830-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T03:24:40Z","timestamp":1760844280000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-19830-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["19830"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-19830-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"28 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"S.B.R. serves as a consultant and scientific advisor to Myolex, Inc., a company that designs impedance devices for clinical and research use, including the one used in this study; he is also a member of the company\u2019s Board of Directors and holds equity in the company. P.S., L.H., G.T., D.P., T.M., J.A.N., A.K.N declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We confirm that animal husbandry and experimental protocols were approved by the Institutional Animal Care and Use Committees at Beth Israel Deaconess Medical Center, in addition they adhere to the Guide for the Care and Use of Laboratory Animals (National Research Council), the provisions of the Animal Welfare Act (USDA), and the National Institute of Health (NIH)\/Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals. This study was conducted as recommended by the ARRIVE guidelines. All procedures and analyses were randomized and blinded; the person performing the randomization was different from the one conducting the experiments and analyses. However, it should be noted that at the second time point (i.e., 40\u00a0weeks), ALS animals exhibited decreased weight as compared to healthy control animals. Therefore, we cannot assume that the experimenter was completely blinded to the experimental group while collecting the EIM and swimming data. However, the experimenter was blinded to the animal\u2019s experimental group during the analysis of these datasets.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"35810"}}